Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches. / S, Pearson; AJK, Williamson; R, Blance et al.
Yn: Leukemia, Cyfrol 31, 01.12.2017.
Yn: Leukemia, Cyfrol 31, 01.12.2017.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
S, P, AJK, W, R, B, TCP, S, S, T, N, A, AD, W & A, P 2017, 'Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches.', Leukemia, cyfrol. 31. https://doi.org/10.1038/leu.2017.143
APA
S, P., AJK, W., R, B., TCP, S., S, T., N, A., AD, W., & A, P. (2017). Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches. Leukemia, 31. https://doi.org/10.1038/leu.2017.143
CBE
S P, AJK W, R B, TCP S, S T, N A, AD W, A P. 2017. Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches. Leukemia. 31. https://doi.org/10.1038/leu.2017.143
MLA
S, Pearson et al. "Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches.". Leukemia. 2017. 31. https://doi.org/10.1038/leu.2017.143
VancouverVancouver
S P, AJK W, R B, TCP S, S T, N A et al. Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches. Leukemia. 2017 Rhag 1;31. doi: 10.1038/leu.2017.143
Author
RIS
TY - JOUR
T1 - Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches.
AU - S, Pearson
AU - AJK, Williamson
AU - R, Blance
AU - TCP, Somervaille
AU - S, Taylor
AU - N, Azadbakht
AU - AD, Whetton
AU - A, Pierce
PY - 2017/12/1
Y1 - 2017/12/1
U2 - 10.1038/leu.2017.143
DO - 10.1038/leu.2017.143
M3 - Erthygl
VL - 31
JO - Leukemia
JF - Leukemia
ER -